EpiSEEK® Focus Epilepsy Panel (76 Genes)

Courtagen’s epiSEEK® Focus Epilepsy Panel provides extensive genetic analysis and clinical interpretation of data generated by the complete sequencing of disease associated genes related to early onset epilepsy and seizure disorders. Knowing the genetic basis of a child’s epilepsy is valuable for obtaining a definitive diagnosis, estimating prognosis, determining recurrence risks, and guiding treatment choices. In many cases, the precise genetic diagnosis can be important in therapy selection.

This test includes syndromic and non-sydromic disorders associated with epilepsy such as Angelman, Angelman-like syndromes, Rett, atypical Rett syndromes, Cerebral folate deficiency, Creatine deficiency syndromes, Mowat-Wilson syndrome, West syndrome, Ohtahara syndrome, Early onset epileptic encephalopathy, Idiopathic generalized epilepsy, Benign familial neonatal seizures (BFNS), Familial infantile myoclonic epilepsy (FIME), Juvenile myoclonic epilepsy, Progressive myoclonic epilepsy, Epilepsy with behavioral and learning disorder.

Del/Dup Additional Analysis (76 genes): Additional analysis of exon-sized (and larger) deletion and duplication variants in 76 genes is available as an add-on for both the epiSEEK Focus and epiSEEK Comprehensive panels.

Product Information Sheets:

epiSEEK® Focus: Epilepsy and Seizure Disorder Panel (76 genes)

epiSEEK® Focus Panel Gene List

Courtagen's Unmatched Customer Support

Turn Around Time: 4-6 weeks. Results are delivered in weeks, not months.

Saliva Sample: DNA for sequencing is reliably extracted from a single saliva sample. No blood draw or muscle biopsy required. (Whole blood and tissue are accepted, as requested.)

Insurance Assistance: Courtagen works with patients, physicians, and insurance carriers to pre-approve each test. Courtagen will bill the insurance company, and is willing to handle an appeal process as needed.

Courtagen Care Financial Assistance Program: Provides financial assistance to patients based on demonstrated financial need. A qualified applicant may be asked to contribute between $0 and a maximum cost sharing of $200 depending on determination of financial need.

Online Portal: A secure physician online portal is available for ordering genetic tests and accessing patient reports when completed.

Genetic Counselors: Available to address physician’s questions regarding Courtagen test results. Contact us at clinical@courtagen.com.

Clinical Experience: Courtagen’s Medical Director, Laboratory Director, and variant science team have over 25 years of experience in the treatment and genetic interpretation of neurological disorders.

Reports: Utilizing Courtagen’s customized Ziphyr® informatics pipeline and thorough clinical evaluation, each report is provided in a concise format with interpretation and recommendations for consideration.

Click here to order a test